Publications
Detailed Information
Nationwide Surveillance Study of Vancomycin-Intermediate Staphylococcus aureus Strains in Korean Hospitals from 2001 to 2006
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chung, Gyungtae | - |
dc.contributor.author | Cha, Jeongok | - |
dc.contributor.author | Han, Sunyoung | - |
dc.contributor.author | Jang, Heesun | - |
dc.contributor.author | Yoo, Jaeil | - |
dc.contributor.author | Kim, Hongbin | - |
dc.contributor.author | Kim, Bongsu | - |
dc.contributor.author | Lee, Yeong Seon | - |
dc.contributor.author | Park, Ok | - |
dc.contributor.author | Eun, Soohoon | - |
dc.contributor.author | Yoo, Jeongsik | - |
dc.contributor.author | Lee, Kyeongmin | - |
dc.date.accessioned | 2012-06-25T07:11:56Z | - |
dc.date.available | 2012-06-25T07:11:56Z | - |
dc.date.issued | 2010-03 | - |
dc.identifier.citation | JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY; Vol.20 3; 637-642 | ko_KR |
dc.identifier.issn | 1017-7825 | - |
dc.identifier.uri | https://hdl.handle.net/10371/77399 | - |
dc.description.abstract | We investigated the prevalence and the molecular characteristics of vancomycin-intermediate Staphylococcus aureus (VISA) among methicillin-resistant Staphylococcus aureus (MRSA) strains isolated from clinical samples at tertiary or general hospitals participating in a nationwide surveillance program for VISA and vancomycin-resistant Staphylococcus aureus (VRSA) in Korea during an 8-week period in each year from 2001 to 2006. Of 41,639 MRSAs isolated, 37,856 were screened and 169 grew on brain heart infusion agar supplemented with 4 mu g/ml vancomycin. A vancomycin MIC of 4 mu g/ml was confirmed for 33 VISA isolates of the 169 isolates. Eighteen of the 33 isolates were classified as hetero-VISA (hVISA) by the population analysis profile (PAP) method. All VISA isolates were susceptible to linezolid, tigecycline, and quinupristin dalfopristin. Most VISA isolates (MIC 4 mu g/ml) showed a PFGE C pattern with sec, seg, and sei enterotoxin genes, including ST5-SCCmec type II, or a PFGE A pattern with sea, including ST239-SCCmec type III. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | KOREAN SOC MICROBIOLOGY & BIOTECHNOLOGY | ko_KR |
dc.subject | Staphylococcus aureus | ko_KR |
dc.subject | vancomycin-intermediate | ko_KR |
dc.subject | surveillance | ko_KR |
dc.title | Nationwide Surveillance Study of Vancomycin-Intermediate Staphylococcus aureus Strains in Korean Hospitals from 2001 to 2006 | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 정경태 | - |
dc.contributor.AlternativeAuthor | 차정옥 | - |
dc.contributor.AlternativeAuthor | 한선영 | - |
dc.contributor.AlternativeAuthor | 장희선 | - |
dc.contributor.AlternativeAuthor | 이경민 | - |
dc.contributor.AlternativeAuthor | 유재일 | - |
dc.contributor.AlternativeAuthor | 유정식 | - |
dc.contributor.AlternativeAuthor | 김홍빈 | - |
dc.contributor.AlternativeAuthor | 은수훈 | - |
dc.contributor.AlternativeAuthor | 김봉수 | - |
dc.contributor.AlternativeAuthor | 박옥 | - |
dc.contributor.AlternativeAuthor | 이영선 | - |
dc.identifier.doi | 10.4014/jmb.0906.06018 | - |
dc.citation.journaltitle | JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY | - |
dc.description.citedreference | Lulitanond A, 2009, J CLIN MICROBIOL, V47, P2311, DOI 10.1128/JCM.01749-08 | - |
dc.description.citedreference | Finks J, 2009, EMERG INFECT DIS, V15, P943, DOI 10.3201/eid1506.081312 | - |
dc.description.citedreference | Rybak MJ, 2008, J CLIN MICROBIOL, V46, P2950, DOI 10.1128/JCM.00582-08 | - |
dc.description.citedreference | Saha B, 2008, J MED MICROBIOL, V57, P72, DOI 10.1099/jmm.0.47144-0 | - |
dc.description.citedreference | Aligholi M, 2008, MED PRIN PRACT, V17, P432, DOI 10.1159/000141513 | - |
dc.description.citedreference | HANAKI H, 2007, J INFECT CHEMOTHER, V13, P118, DOI 10.1007/s10156-006-0498-z | - |
dc.description.citedreference | Goldstein F, 2007, J ANTIMICROB CHEMOTH, V59, P1, DOI 10.1093/jac/dkl429 | - |
dc.description.citedreference | Tiwari HK, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-156 | - |
dc.description.citedreference | Cui LZ, 2006, ANTIMICROB AGENTS CH, V50, P1079, DOI 10.1128/AAC.50.3.1079-1082.2006 | - |
dc.description.citedreference | Robert J, 2006, J ANTIMICROB CHEMOTH, V57, P506, DOI 10.1093/jac/dki486 | - |
dc.description.citedreference | Kim HB, 2006, MICROB DRUG RESIST, V12, P33 | - |
dc.description.citedreference | *CLIN LAB STAND I, 2006, M7A7 CLSI | - |
dc.description.citedreference | Van Griethuysen AA, 2003, J CLIN MICROBIOL, V41, P2487, DOI 10.1128/JCM.41.6.2487-2491.2003 | - |
dc.description.citedreference | Moore MR, 2003, ANTIMICROB AGENTS CH, V47, P1262, DOI 10.1128/AAC.47.4.1262-1266.2003 | - |
dc.description.citedreference | Denis O, 2002, J ANTIMICROB CHEMOTH, V50, P383, DOI 10.1093/jac/dkf142 | - |
dc.description.citedreference | Hussain FM, 2002, J INFECT DIS, V186, P661 | - |
dc.description.citedreference | Oliveira DC, 2002, ANTIMICROB AGENTS CH, V46, P2155, DOI 10.1128/AAC.46.7.2155-2161.2002 | - |
dc.description.citedreference | Kim MN, 2002, J CLIN MICROBIOL, V40, P1376, DOI 10.1128/JCM.40.4.1376-1380.2002 | - |
dc.description.citedreference | *CDCP, 2002, MMWR-MORBID MORTAL W, V51, P565 | - |
dc.description.citedreference | Ike Y, 2001, J CLIN MICROBIOL, V39, P4445 | - |
dc.description.citedreference | Reverdy ME, 2001, CLIN MICROBIOL INFEC, V7, P267 | - |
dc.description.citedreference | Wootton M, 2001, J ANTIMICROB CHEMOTH, V47, P399 | - |
dc.description.citedreference | Kim MN, 2000, J CLIN MICROBIOL, V38, P3879 | - |
dc.description.citedreference | Lee K, 2000, YONSEI MED J, V41, P497 | - |
dc.description.citedreference | Guerin F, 2000, J CLIN MICROBIOL, V38, P2985 | - |
dc.description.citedreference | Marchese A, 2000, J CLIN MICROBIOL, V38, P866 | - |
dc.description.citedreference | *CDCP, 2000, MMWR-MORBID MORTAL W, V48, P1165 | - |
dc.description.citedreference | Monday SR, 1999, J CLIN MICROBIOL, V37, P3411 | - |
dc.description.citedreference | Bierbaum G, 1999, EUR J CLIN MICROBIOL, V18, P691 | - |
dc.description.citedreference | Wong SSY, 1999, CLIN INFECT DIS, V29, P760 | - |
dc.description.citedreference | Smith TL, 1999, NEW ENGL J MED, V340, P493 | - |
dc.description.citedreference | Sieradzki K, 1999, NEW ENGL J MED, V340, P517 | - |
dc.description.citedreference | Becker K, 1998, J CLIN MICROBIOL, V36, P2548 | - |
dc.description.citedreference | POLY MC, 1998, LANCET, V351, P1212 | - |
dc.description.citedreference | Hiramatsu K, 1997, LANCET, V350, P1670 | - |
dc.description.citedreference | Hiramatsu K, 1997, J ANTIMICROB CHEMOTH, V40, P135 | - |
dc.description.citedreference | TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233 | - |
dc.description.citedreference | CLARK NC, 1993, ANTIMICROB AGENTS CH, V37, P2311 | - |
dc.description.tc | 5 | - |
- Appears in Collections:
- Files in This Item:
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.